Figure 3
From: High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) analysis. Observed survival of SDC patients is depicted according to the presence or absence of genetic abnormalities: A. mutations in PIK3CA and B. mutations in ERBB2. Statistical analysis revealed no significant differences but indicated a trend toward better survival for patients without genetic mutation.